Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure. Am J Cardiovasc Drugs • June 21, 2019
Assessment of Non-vitamin K Oral Anticoagulants Use in a Tertiary Care Center in the USA: A Chart Review of 909 Patients. Am J Cardiovasc Drugs • June 18, 2019
Anticoagulation in Venous Thromboembolism Prophylaxis in Medically Ill Patients: Potential Impact of NOACs. Am J Cardiovasc Drugs • February 28, 2019
Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study. Am J Cardiovasc Drugs • September 27, 2018
Pharmacologic treatment of hypertension in patients with chronic kidney disease. Am J Cardiovasc Drugs • January 23, 2014
Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation. Am J Cardiovasc Drugs • April 30, 2013
Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction. Am J Cardiovasc Drugs • April 30, 2013
Oral antiplatelet therapy in the secondary prevention of atherothrombotic events. Am J Cardiovasc Drugs • August 25, 2009
Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs • August 25, 2009